Literature DB >> 19127474

An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments.

Kayode Ogungbenro1, Leon Aarons.   

Abstract

This paper describes an effective approach for optimizing sampling windows for population pharmacokinetic experiments. Sampling windows has been proposed for population pharmacokinetic experiments that are conducted in late phase drug development programs where patients are enrolled in many centers and out-patient clinic settings. Collection of samples under this uncontrolled environment at fixed times may be problematic and can result in uninformative data. A sampling windows approach is more practicable, as it provides the opportunity to control when samples are collected by allowing some flexibility and yet provide satisfactory parameter estimation. This approach uses D-optimality to specify time intervals around fixed D-optimal time points that results in a specified level of efficiency. The sampling windows have different lengths and achieve two objectives: the joint sampling windows design attains a high specified efficiency level and also reflects the sensitivities of the plasma concentration-time profile to parameters. It is shown that optimal sampling windows obtained using this approach are very efficient for estimating population PK parameters and provide greater flexibility in terms of when samples are collected.

Entities:  

Mesh:

Year:  2009        PMID: 19127474     DOI: 10.1080/10543400802536131

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  5 in total

1.  Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experiments.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-06-10       Impact factor: 2.745

2.  A sequential Monte Carlo approach to derive sampling times and windows for population pharmacokinetic studies.

Authors:  J M McGree; C C Drovandi; A N Pettitt
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-07-31       Impact factor: 2.745

3.  Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Kana Mizuno; Min Dong; Tsuyoshi Fukuda; Sharat Chandra; Parinda A Mehta; Scott McConnell; Elias J Anaissie; Alexander A Vinks
Journal:  Clin Pharmacokinet       Date:  2018-05       Impact factor: 6.447

4.  Population pharmacokinetics and optimal design of paediatric studies for famciclovir.

Authors:  Kayode Ogungbenro; Ivan Matthews; Michael Looby; Guenther Kaiser; Gordon Graham; Leon Aarons
Journal:  Br J Clin Pharmacol       Date:  2009-10       Impact factor: 4.335

5.  Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients.

Authors:  Spinel Karas; Amy S Etheridge; Eleftheria Tsakalozou; Jacqueline Ramírez; Erika Cecchin; Ron H N van Schaik; Giuseppe Toffoli; Mark J Ratain; Ron H J Mathijssen; Alan Forrest; Robert R Bies; Federico Innocenti
Journal:  AAPS J       Date:  2020-03-17       Impact factor: 4.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.